Circulating cytokines in Alzheimer's disease

Journal of Psychiatric Research

Volumn 31, Issue 6, 1997, Pages 657-660

  Singh, Vijendra K ^a,b   Guthikonda, Padma ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 12; INTERLEUKIN 6;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; BLOOD LEVEL; CLINICAL ARTICLE; FEMALE; HUMAN; MALE; PATHOPHYSIOLOGY; PRIORITY JOURNAL;

AGED; ALZHEIMER DISEASE; BLOOD-BRAIN BARRIER; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; INTERFERON TYPE II; INTERFERON-ALPHA; INTERLEUKINS; MALE; MIDDLE AGED; T-LYMPHOCYTES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0030775197     PISSN: 00223956     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-3956(97)00023-X     Document Type: Article

References (15)

1. Araga, S., Kagimoto, H., Funamoto, K., & Takahashi, K. (1991). Reduced natural killer cell activity in patients with dementia of the Alzheimer's type. Acta Neurologica Scandinavica, 84, 259-263.
2. Arai, K., Lee, F., Miyajima, A., Shichiro, M., Naoko, A., & Yokota, T. (1990). Cytokines: coordinators of immune and inflammatory responses. Annual Review of Biochemistry, 59, 783-836.
3. Bauer, J., Ganter, U., Strauss, S., Stadtmuller, G., Frommberger, U., Bauer, H., Volk, B., & Berger, M. (1992). The participation of interleukin-6 in the pathogenesis of Alzheimer's disease. Research in Immunology, 143, 650-657.
4. Esumi, E., Araga, S., & Takahashi, K. (1991). Serum interleukin-2 levels in patients with dementia of the Alzheimer's type. Acta Neurolologica Scandinavica, 84, 65-67.
5. Fillit, H., Ding, W. H., Buee, L., Kalman, J., Allstiel, L., Lawlor, B., & Wolf-Klein, G. (1991). Elevated circulating tumor necrosis factor levels in Alzheimer's disease. Neuroscience Letters, 129, 318-320.
6. Griffin, D. E., Ward, B. J., Jauregui, E., Johnson, R. T., & Vaisberg, A. (1990). Immune activation during measles: interferon-g and neopterin in plasma and cerebrospinal fluid in complicated and uncomplicated disease. Journal of Infectious Diseases, 161, 449-453.
7. Huberman, M., Shalit, F., Roth-Deri, I., Gutman, B., Kott, E., & Sredni, B. (1994). Correlation of cytokine secretion by mononuclear cells of Alzheimer' disease and disease stage. Journal of Neuroimmunology 52, 147-152.
8. Ikeda, T., Yamamoto, K., Takahashi, K., Kaneyuki, H., & Yamada, M. (1991). Interleukin-2 receptor in peripheral blood lymphocytes of Alzheimer's disease patients. Acta Psychiatrica Scandinavica, 84, 262-265.
9. McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., Stadlan, E. M. (1984). Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services task force on Alzheimer's disease. Neurology, 34, 939-944.
10. Singh, V. K. (1990). Neuroimmune axis as a basis of therapy in Alzheimer's disease. Progress in Drug Research, 34, 383-393.
11. Singh, V. K. (1994). Studies of neuroimmune markers in Alzheimer's disease. Molecular Neurobiology, 9, 73-81.
12. Singh, V. K. (1996a). Immune-activation model in Alzheimer's disease. Molecular and Chemical Neuropathology, 28, 105-111.
13. Singh, V. K. (1996b). Plasma increase of interleukin-12 and interferon-gamma: pathological significance in autism. Journal of Neuroimmunology, 66, 143-145.
14. Singh, V. K., Warren, R. P., Odell, J. D., & Cole, P. (1991). Changes of soluble interleukin-2, interleukin-2 receptor, T8 antigen, and interleukin-1 in the serum of autistic children. Clinical and Immunological Immunopathology, 61, 448-455.
15. Trinchieri, G. (1993). Interleukin-12 and its role in the generation of TH1 cells. Immunology Today, 14, 335-338.